Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT04694092
Eligibility Criteria:
Inclusion Criteria:
* acute heart failure with reduced left ventricular ejection (\<40%)
* atrial fibrillation with heart rate \>130/min lasting presumably \>12 hours and presumably contributing to the acute heart failure
* pulmonary congestion detected by auscultation, lung ultrasound or CXR
Exclusion Criteria:
* ongoing type 1. myocardial infarction
* cardiogenic shock
* presumed need for mechanical heart support during the first 48hours of the study
* presumed need for electric cardioversion during the first 2 hours of the study
* medication for heart rate control (beta-blockers, calcium channel blockers, digoxin) or antiarrhythmics introduced \<24 hours before the study. Chronic therapy with these will not be a contraindication for the study
* thyreotoxicosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04694092
Study Brief:
Protocol Section:
NCT04694092